Ovoca Bio Regulatory News (OVB)

Ovoca Bio PLC

3 March 2025

Ovoca Bio plc

 ("Ovoca" or the "Company")

Management Changes

Dublin, Ireland, 3 March 2025 - Ovoca Bio, a biopharmaceutical company with a focus on women's health, is pleased to announce the appointment of Ms. Leah O'Donovan as its Chief Financial Officer with immediate effect.

Ms. O'Donovan is a professional accountant with over 15 years' experience working in the accounting and financial services industries. Prior to joining Ovoca, she was a Senior Financial Controller at Grant Thornton, Senior Financial Accountant at CNP Santander Insurance, and worked at such institutions as MetLife and Maples Fiduciary Services.

Timothy McCutcheon, Ovoca's CEO, said "We welcome Leah to our team and look forward to working with her for the benefit of all Ovoca stakeholders. I would like to thank Dmitriy Nikitashenko for his service and wish him well in his future endeavors."

The role of Chief Financial Officer is not a Board position at present.

End

For further information:

Ovoca Bio plc

Timothy McCutcheon (Chief Executive)

Tel +353 1 661 9819

info@ovocabio.com

Davy (Nominated Adviser, Euronext Growth Listing Sponsor and Broker)

Ivan Murphy / Daragh O'Reilly

Tel: +353 1 679 6363